Investors
Boehringer Ingelheim Venture Fund
https://boehringer-ingelheim-venture.comBoehringer Ingelheim Venture Fund invests in early-stage biotech and health tech companies aiming to improve health and medicine. They focus on seed and Series A funding to support startups in developing their products. Notable investments include Asgard Therapeutics and Glox Therapeutics.
Recent Investments
- Asgard TherapeuticsSeries A( 41 )
- HepaRegeniXSeries C( 48 )
- Glox TherapeuticsSeed( 28 )